Small.png_thumb90

Daniela Josefa Díaz Catalán

Postdoctotal Researcher

Universidad Mayor de Chile

Santiago, Chile

Líneas de Investigación


My research integrates molecular and computational approaches to study metabolic diseases, endocrine dysfunctions, and translational biomedical applications, aiming to advance precision medicine and patient outcomes.

Educación

  •  Biomedicine, UNIVERSIDAD DE BARCELONA. España, 2021
  •  Bioinformatic and Biostatistic, UNIVERSIDAD OBERTA DE CATALUNYA. Chile, 2024
  •  Biomedical Research, UNIVERSITAT POMPEU FABRA. España, 2016
  •  Médico Veterinario, UNIVERSIDAD MAYOR. Chile, 2014

Experiencia Profesional

  •   Junior Biostatistician Full Time

    European Foundation Chonic Liver Failure (EF CLIF)

    Barcelona, España

    2024 - 2025

  •   Junior Bioinformatician Scientist Full Time

    Hospital del Mar Research Institute (IMIM)

    Barcelona, España

    2024 - 2024

  •   Postdoc Scientist Full Time

    August Pi Sunyer Biomedical Research Institute (IDIBAPS)

    Barcelona, España

    2021 - 2023

  •   Predoctoral Scientist Full Time

    August Pi Sunyer Biomedical Research Institute (IDIBAPS)

    Barcelona, España

    2017 - 2021

  •   Master Scientist Full Time

    Barcelona University

    Barcelona, España

    2016 - 2016

  •   Research Assistant Part Time

    Universitat Oberta de Catalunya

    Barcelona, España

    2025 - A la fecha

  •   Postdoc Scientist Full Time

    Universidad Mayor

    Santiago, Chile

    2025 - A la fecha

Difusión y Transferencia


Publications:
- Authored 10 peer-reviewed articles in high-impact journals such as Molecular Metabolism and Scientific Reports. These publications address critical topics like the metabolic consequences of BACE2 suppression in obesity and the therapeutic potential of FGF21 in Cushing syndrome.
- Contributions to interdisciplinary research have bridged molecular biology, clinical applications, and computational analysis.

Conference Presentations:
- Presented at 9 international conferences, including prestigious events like the European Congress of Endocrinology (ECE) and the Sociedad Española de Endocrinología y Nutrición (SEEN).
- Delivered oral presentations and posters on topics ranging from fibroblast growth factor 21's role in adrenal renewal to BACE2 deficiency's impact on metabolic health.
- Recognized with the Best Oral Presentation Award at the III Biomed PhD Day (2019), highlighting your ability to communicate complex scientific findings effectively.

Knowledge Transfer Initiatives:
- Coordinated the Red de Investigadores/as Chilenos/as en España (RedINCHE), creating spaces for reflection and dissemination in biomedicine.
- Co-coordinated the session on biomedicine at the "Red Encuentros Barcelona 2016," fostering collaboration among researchers.

Collaborations:
- Worked with international teams, such as Dr. Vallejo's group at IIBM Alberto Sols (Madrid) and Dr. Claret's team at IDIBAPS, to advance calorimetry and appetite regulation research.
- Supervised master's theses and undergraduate projects, contributing to capacity building in biomedical research.


Premios y Distinciones

  •   PREDOCTORAL FELLOWSHIP CONICYT

    UNIVERSIDAD DE BARCELONA

    Chile, 2016

    Programa de fromación de Capital humano Avanzado de la Comisión Nacional de Investigación Científica y Tecnológica (CONICYT)

  •   FELLOWSHIP

    European Society Endocronology Young Endocrinologists and Scientists (EYES)

    Croacia, 2022

    FELLOWSHIP from European Society Endocronology Young Endocrinologists and Scientists (EYES) to 9th European Society Endocronology Young Endocrinologists and Scientists (EYES) meeting.

  •   FELLOWSHIP

    European Association for the Study of Diabetes (EASD)

    Francia, 2018

    FELLOWSHIP from European Association for the Study of Diabetes (EASD) to assit Scientists Training Course.

  •   BEST ORAL PRESENTATION

    Universitat de Barcelona

    España, 2019

    BEST ORAL PRESENTATION “Bace2 as a new therapeutic target for the treatment of obesity and type 2 Diabetes” III Biomed PhD day.


 

Article (7)

Sex-dependent effects of FGF21 on HPA axis regulation and adrenal regeneration after Cushing syndrome in mice
Hair cortisol and changes in cortisol dynamics in chronic kidney disease
Midnight Cortisol is Associated with Changes in Systolic Blood Pressure and Diabetic Neuropathy in Subjects with Type 1 Diabetes Undergoing Simultaneous Kidney-Pancreas Transplantation
Ketoconazole- and Metyrapone-Induced Reductions on Urinary Steroid Metabolites Alter the Urinary Free Cortisol Immunoassay Reliability in Cushing Syndrome
4-Phenylbutyrate (PBA) treatment reduces hyperglycemia and islet amyloid in a mouse model of type 2 diabetes and obesity
BACE2 suppression in mice aggravates the adverse metabolic consequences of an obesogenic diet
Alpha1-antitrypsin ameliorates islet amyloid-induced glucose intolerance and (3-cell dysfunction

ConferencePaper (2)

8092 Senecence Cell Accumulation In Cushing Syndrome
Effects of Fibroblast factor 21 to adrenal renewal after chronic hypercortisolism

ConferencePoster (3)

Fibroblast growth factor 21 contributes to adrenal cortex renewal
Patients with chronic kidney disease present HPA axis disregulation due to impaired glucocorticoid negative feedback
Pre and post-surgical pituitary dysfunction increase the risk of mortality in patients with non-functioning pituitary tumors: A long-term cohort study
12
Daniela Díaz

Postdoctotal Researcher

Facultad de Medicina y Ciencias de la Salud

Universidad Mayor de Chile

Santiago, Chile